Startups
Urologix, Inc. develops, markets and distributes advanced minimally invasive medical devices for the in-office, non-surgical treatment of Benign Prostatic Hyperplasia (BPH) also known as Enlarged Prostate. Over 200,000 Urologix procedures have been performed to date.
Both Cooled ThermoTherapy™ and Prostiva RF Therapy are safe, non-surgical in-office treatments which provide long-term relief from BPH symptoms and urinary obstruction without the side effects and high cost of chronic BPH medication or the risks and associated with invasive surgery. Both treatments should result in a significant improvement from bothersome symptoms such as the frequent need to urinate during the day and night, a sense of urgency to urinate, and low urine flow.*,**
Cooled ThermoTherapy delivers targeted microwave heat to destroy excess prostate tissue and includes an advanced urethral cooling system providing enhanced protection for the healthy urethra as well as increased patient comfort.
Prostiva® RF Therapy delivers precisely targeted low-level radio frequency (RF) energy that produces heat to destroy the excess prostate tissue. After the treatment, the prostate tissue will shrink, allowing the patient to urinate more normally.
Both of these products provide safe, effective and lasting relief of BPH symptoms. They are performed in a urologist's office, do not require general anesthesia and can be completed in less than an hour.
Please visit http://www.urologix.com for more information.
Prostiva® is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.
---
*Mynderse LA, Roehrborn CG, et al. Results of a 5-Year Multicenter Trial of a New Generation Cooled High Energy Transurethral Microwave Thermal Therapy Catheter for Benign Prostatic Hyperplasia. Journal of Urology. Vol. 185, 1804-1811, May 2011
**Hill, B., et al Transurethreal Needle Ablation vs TURP for the Treatment of Symptomatic BPH: 5 Year Results of a Prospective, Randomized, Multicenter Clinical Trial, Journal of Urology Vol 171, 2336-2340, June 2004
Both Cooled ThermoTherapy™ and Prostiva RF Therapy are safe, non-surgical in-office treatments which provide long-term relief from BPH symptoms and urinary obstruction without the side effects and high cost of chronic BPH medication or the risks and associated with invasive surgery. Both treatments should result in a significant improvement from bothersome symptoms such as the frequent need to urinate during the day and night, a sense of urgency to urinate, and low urine flow.*,**
Cooled ThermoTherapy delivers targeted microwave heat to destroy excess prostate tissue and includes an advanced urethral cooling system providing enhanced protection for the healthy urethra as well as increased patient comfort.
Prostiva® RF Therapy delivers precisely targeted low-level radio frequency (RF) energy that produces heat to destroy the excess prostate tissue. After the treatment, the prostate tissue will shrink, allowing the patient to urinate more normally.
Both of these products provide safe, effective and lasting relief of BPH symptoms. They are performed in a urologist's office, do not require general anesthesia and can be completed in less than an hour.
Please visit http://www.urologix.com for more information.
Prostiva® is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.
---
*Mynderse LA, Roehrborn CG, et al. Results of a 5-Year Multicenter Trial of a New Generation Cooled High Energy Transurethral Microwave Thermal Therapy Catheter for Benign Prostatic Hyperplasia. Journal of Urology. Vol. 185, 1804-1811, May 2011
**Hill, B., et al Transurethreal Needle Ablation vs TURP for the Treatment of Symptomatic BPH: 5 Year Results of a Prospective, Randomized, Multicenter Clinical Trial, Journal of Urology Vol 171, 2336-2340, June 2004
Overview
Location
United States, Minnesota, Plymouth
Phone
+1 888-229-0772
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 10, 2010 | Urologix hires new finance chief | “In addition to his accounting experience in a public medical technology company, Brian brings to Urologix a strong background in financial analysis, planning and strategy,” CEO Stryker Warren Jr. said. Urologix develops devices that treat ... |
| May 5, 2010 | Minnesota’s public medical companies not named Medtronic are shrinking | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| May 5, 2010 | Minnesota’s medical device cluster consolidates | By Thomas Lee Ernie Andberg has a little more free time on his hands these days. The longtime “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, th... |
| Massachusetts-based device company raises $34.76 million to fund US pivotal clinical trial, execute commercial strategy abroad | GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier Therapy, which it claims can reduce blood-sugar levels and offer weight-loss results in Type 2 Diabetes patients, has raised $34,755,000 in equity and CDIs, accor... | |
| Minnesota’s public medical companies not named Medtronic are shrinking | Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been di... | |
| Urologix hires new finance chief | Urologix Inc. (Nasdaq: ULGX) has hired a new chief financial officer who previously worked as a controller for device firm Angeion Corp. Brian Smrdel takes over the CFO role from Rebecca Weber, who will stay on as Urologix’s director of fin... |
Reviews 0
FAQ about Urologix Inc.
What has the press written about Urologix Inc.?
Parsers VC has collected 7 articles mentioning Urologix Inc., among them “Urologix hires new finance chief” (May 10, 2010) and “Minnesota’s public medical companies not named Medtronic are shrinking” (May 5, 2010).
Is Urologix Inc. still active?
Yes, Urologix Inc. is active; its latest activity on Parsers VC dates from Oct 31, 2024.